Vol 7, No 4 (2022)
Original article
Published online: 2022-10-26
Post-COVID-19 rehabilitation (PCR-SIRIO 8) study. A rationale and protocol of the study
1
, 1, 1, 1, 1, 2, 2, 3, 2
, 1, 1, 1, 1, 2, 2, 3, 2
Medical Research Journal 2022;7(4):280-283.
Abstract
A substantial proportion of the COVID-19 survivors require the physical and mental support due to the post COVID-19 syndrome. In response to this demand a comprehensive rehabilitation program tailored to the individual needs has been developed. The program is linked with a Post-COVID-19 Rehabilitation (PCR-SIRIO 8) study that aims to objectively evaluate the outcomes of the post-COVID-19 rehabilitation.
The study was designed as a prospective, single-center, observational study involving patients suffering from post-COVID-19 syndrome. Patients meeting the inclusion criteria are invited for an initial visit including medical and physiotherapeutic examination. Rehabilitation program includes physical training, therapeutic education, and psychotherapeutic workshops. Individual psychotherapeutic, educational and medical visits are carried out additionally depending on the patient’s needs. Closing visit evaluates individual effects of the rehabilitation program.
We believe that our observational study will provide knowledge necessary to optimize post-COVID-19 rehabilitation.
Keywords: COVID-19rehabilitation
References
- Paciorek P, Romaniuk M, Husejko J, et al. Impact of COVID-19 pandemic on emergency medical service response to emergency calls — a retrospective analysis of data from Emergency Medical Service station in Bydgoszcz. Medical Research Journal. 2022; 7(3): 190–196.
- Nadolny K, Ładny JR, Zyśko D, et al. Interventions of emergency medical teams in Poland during the SARS-CoV-2 pandemic. Kardiol Pol. 2021; 79(1): 72–75.
- Ratajczak J, Szczerbiński S, Kubica A. Occurrence and Temporal Variability of Out-of-Hospital Cardiac Arrest during COVID-19 Pandemic in Comparison to the Pre-Pandemic Period in Poland-Observational Analysis of OSCAR-POL Registry. J Clin Med. 2022; 11(14): 4143.
- Szczerbiński S, Ratajczak J, Jasiewicz M, et al. Observational analysiS of out-of-hospital Cardiac Arrest occurRence and temporal variability patterns in subpopulation of southern POLand from 2006 to 2018: OSCAR-POL registry. Cardiol J. 2021 [Epub ahead of print].
- Kubica J, Podhajski P, Magielski P, et al. IMPACT of PCSK9 inhibition on clinical outcome in patients during the inflammatory stage of the SARS-COV-2 infection: Rationale and protocol of the IMPACT-SIRIO 5 study. Cardiol J. 2022; 29(1): 140–147.
- Szczerbinski S, Ratajczak J, Lach P, et al. Epidemiology and chronobiology of out-of-hospital cardiac arrest in a subpopulation of southern Poland: A two-year observation. Cardiol J. 2020; 27(1): 16–24.
- Bielski K, Szarpak A, Jaguszewski MJ, et al. The influence of COVID-19 on out-hospital cardiac arrest survival outcomes: an updated systematic review and meta-analysis. J Clin Med. 2021; 10(23): 5573.
- Nadolny K, Szczerbiński S, Ładny J, et al. Out-of-hospital cardiac arrest and COVID-19 pandemic. Medical Research Journal. 2021; 6(2): 83–85.
- Kubica J, Ostrowska M, Stolarek W, et al. Impact of COVID-19 pandemic on acute heart failure admissions and mortality: a multicentre study (COV-HF-SIRIO 6 study). ESC Heart Fail. 2022; 9(1): 721–728.
- Ostrowska M, Kasprzak M, Stolarek W, et al. Longer hospitalizations and higher in-hospital mortality for acute heart failure during the COVID-19 pandemic in larger vs. smaller cardiology departments: subanalysis of the COV-HF-SIRIO 6 multicenter study. Rev Cardiovasc Med. 2022; 23(9): 292.
- Lackowski P, Piasecki M, Kasprzak M, et al. COVID-19 pandemic year in the cardiology department. Medical Research Journal. 2021; 6(1): 40–46.
- Granström J, Lantz P, Lidin M, et al. Perceptions of delay when afflicted by an acute myocardial infarction during the first wave of the COVID-19 pandemic. Eur J Cardiovasc Nurs. 2022 [Epub ahead of print].
- Akbarialiabad H, Taghrir MH, Abdollahi A, et al. Long COVID, a comprehensive systematic scoping review. Infection. 2021; 49(6): 1163–1186.
- Friedman KJ, Murovska M, Pheby DFH, et al. Our evolving understanding of ME/CFS. Medicina (Kaunas). 2021; 57(3): 200.
- Kubica A, Michalski P, Kasprzak M, et al. Functioning of patients with post-COVID syndrome — preliminary data. Medical Research Journal. 2021; 6(3): 224–229.
- Kubica A. Self-reported questionnaires for a comprehensive assessment of patients after acute coronary syndrome. Medical Research Journal. 2019; 4(2): 106–109.
- Michalski P, Kasprzak M, Kosobucka A, et al. Sociodemographic and clinical determinants of the functioning of patients with coronary artery disease. Medical Research Journal. 2021; 6(1): 21–27.
- Buszko K, Pietrzykowski Ł, Michalski P, et al. Validation of the Functioning in Chronic Illness Scale (FCIS). Medical Research Journal. 2018; 3(2): 63–69.
- Kubica A, Kosobucka A, Michalski P, et al. Self-reported questionnaires for assessment adherence to treatment in patients with cardiovascular diseases. Medical Research Journal. 2017; 2(4): 115–122.
- Kubica A, Adamski P, Bączkowska A, et al. The rationale for Multilevel Educational and Motivational Intervention in Patients after Myocardial Infarction (MEDMOTION) project is to support multicentre randomized clinical trial Evaluating Safety and Efficacy of Two Ticagrelor-based De-escalation Antiplatelet Strategies in Acute Coronary Syndrome (ELECTRA – SIRIO 2). Medical Research Journal. 2020; 5(4): 244–249.
- Kubica A, Kosobucka A, Fabiszak T, et al. Assessment of adherence to medication in patients after myocardial infarction treated with percutaneous coronary intervention. Is there a place for newself-reported questionnaires? Curr Med Res Opin. 2019; 35(2): 341–349.
- Kosobucka A, Michalski P, Pietrzykowski Ł, et al. Adherence to treatment assessed with the Adherence in Chronic Diseases Scale in patients after myocardial infarction. Patient Prefer Adherence. 2018; 12: 333–340.
- Kubica A, Obońska K, Fabiszak T, et al. Adherence to antiplatelet treatment with P2Y12 receptor inhibitors. Is there anything we can do to improve it? A systematic review of randomized trials. Curr Med Res Opin. 2016; 32(8): 1441–1451.
- Kubica A, Obońska K, Kasprzak M, et al. Prediction of high risk of non-adherence to antiplatelet treatment. Kardiol Pol. 2016; 74(1): 61–67.
- Pietrzykowski Ł, Michalski P, Kosobucka A, et al. Knowledge about health and disease in obese patients after myocardial infarction. An observational study. Medical Research Journal. 2018; 2(4): 135–140.
- Michalski P, Kosobucka A, Pietrzykowski Ł, et al. Effectiveness of therapeutic education in patients with myocardial infarction. Medical Research Journal. 2017; 2(3): 89–96.
- Kubica A, Bączkowska A. Uzasadnienie interwencji motywacyjnych jako kluczowego elementu projektu wielopoziomowej edukacji i motywacji u pacjentów z zawałem serca (MEDMOTION). Folia Cardiologica. 2020; 15(1): 6–10.
- Kubica A, Gruchała M, Jaguszewski M, et al. Adherence to treatment — a pivotal issue in long-term treatment of patients with cardiovascular diseases. An expert standpoint. Medical Research Journal. 2018; 2(4): 123–127.
- Michalski P, Kasprzak M, Siedlaczek M, et al. The impact of knowledge and effectiveness of educational intervention on readiness for hospital discharge and adherence to therapeutic recommendations in patients with acute coronary syndrome. Medical Research Journal. 2020; 5(2): 72–78.
- Pietrzykowski Ł, Kasprzak M, Michalski P, et al. The influence of patient expectations on adherence to treatment regimen after myocardial infarction. Patient Educ Couns. 2022; 105(2): 426–431.
- Pietrzykowski Ł, Kasprzak M, Michalski P, et al. Therapy Discontinuation after Myocardial Infarction. J Clin Med. 2020; 9(12): 4109.
- Pietrzykowski Ł, Michalski P, Kosobucka A, et al. Medication adherence and its determinants in patients after myocardial infarction. Sci Rep. 2020; 10(1): 12028.
- Kubica A, Kasprzak M, Obońska K, et al. Discrepancies in assessment of adherence to antiplatelet treatment after myocardial infarction. Pharmacology. 2015; 95(1-2): 50–58.
- Kubica A, Kasprzak M, Siller-Matula J, et al. Time-related changes in determinants of antiplatelet effect of clopidogrel in patients after myocardial infarction. Eur J Pharmacol. 2014; 742: 47–54.
- Barker-Davies RM, O'Sullivan O, Senaratne KP, et al. The Stanford Hall consensus statement for post-COVID-19 rehabilitation. Br J Sports Med. 2020; 54(16): 949–959.
- Phillips M, Turner-Stokes L, Wade D et al. Rehabilitation in the wake of Covid-19 - A phoenix from the ashes. https://www.bsrm.org.uk/downloads/covid-19bsrmissue1-published-27-4-2020.pdf (16.09.2022).